GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (OTCPK:ACHKF) » Definitions » Cash Flow from Financing

Achiko AG (Achiko AG) Cash Flow from Financing : $4.48 Mil (TTM As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Achiko AG Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Jun. 2022, Achiko AG paid $0.00 Mil more to buy back shares than it received from issuing new shares. It received $1.43 Mil from issuing more debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $0.00 Mil on other financial activities. In all, Achiko AG earned $1.43 Mil on financial activities for the six months ended in Jun. 2022.


Achiko AG Cash Flow from Financing Historical Data

The historical data trend for Achiko AG's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Cash Flow from Financing Chart

Achiko AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21
Cash Flow from Financing
- 4.60 4.78 5.72

Achiko AG Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Cash Flow from Financing Get a 7-Day Free Trial 0.10 4.68 2.67 3.05 1.43

Achiko AG Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Achiko AG's Cash from Financing for the fiscal year that ended in Dec. 2021 is calculated as:

Achiko AG's Cash from Financing for the quarter that ended in Jun. 2022 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $4.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Achiko AG  (OTCPK:ACHKF) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Achiko AG's issuance of stock for the six months ended in Jun. 2022 was $0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Achiko AG's repurchase of stock for the six months ended in Jun. 2022 was $0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Achiko AG's net issuance of debt for the six months ended in Jun. 2022 was $1.43 Mil. Achiko AG received $1.43 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Achiko AG's net issuance of preferred for the six months ended in Jun. 2022 was $0.00 Mil. Achiko AG paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Achiko AG's cash flow for dividends for the six months ended in Jun. 2022 was $0.00 Mil. Achiko AG received $0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Achiko AG's other financing for the six months ended in Jun. 2022 was $0.00 Mil. Achiko AG received $0.00 Mil on other financial activities.


Achiko AG Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Achiko AG's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Achiko AG (Achiko AG) Business Description

Traded in Other Exchanges
N/A
Address
Tessinerplatz 7, Zurich, CHE, CH-8002
Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.

Achiko AG (Achiko AG) Headlines